Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
10,160
+80 (0.79%)
Mar 27, 2025, 3:30 PM KST
KRX:007570 Revenue
Ilyang Pharmaceutical Co.,Ltd had revenue of 99.14B KRW in the quarter ending September 30, 2024, a decrease of -1.48%. This brings the company's revenue in the last twelve months to 364.56B, down -0.78% year-over-year. In the year 2023, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 370.54B, down -3.46%.
Revenue (ttm)
364.56B
Revenue Growth
-0.78%
P/S Ratio
0.50
Revenue / Employee
572.31M
Employees
637
Market Cap
182.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 370.54B | -13.27B | -3.46% |
Dec 31, 2022 | 383.81B | 12.46B | 3.36% |
Dec 31, 2021 | 371.35B | 28.02B | 8.16% |
Dec 31, 2020 | 343.33B | 18.76B | 5.78% |
Dec 31, 2019 | 324.57B | 24.54B | 8.18% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |